top of page

Biosafety Laboratory Facility (BSL)-3


Following the COVID-19 epidemics, we have secured funding from the Brazilian Scientific Research Council (CNPq) to develop a novel BCG-based SARS-Cov-2 vaccine. We are happy to inform the scientific community that the construction of our BSL-3 facility has been initiated. 

 The new BSL-3 Facility

bottom of page